RxDoctor Payments Data

Adrianne Gasper, NP

Nurse Practitioner · Winter Park, FLNPI 1386965085

Payments from drug & device makers

$4,736in general payments, 2019–2025

Across 51 payments — averaging $92.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • MDD US Operations, LLC$2K
  • Medtronic$1K
  • Boston Scientific$671
  • Abbott$566
  • Kyowa Kirin, Inc.$21

What the payments were for

  • Speaking & faculty fees$1,17025%
  • Travel & lodging$1,93341%
  • Food & beverage$1,63434%

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
MDD US Operations, LLC20$2,287
Medtronic20$1,191
Boston Scientific4$671
Abbott6$566
Kyowa Kirin, Inc.1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,736 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Medicare billing

Part B allowed, 2024
$58,941
Medicare patients
183
Services billed
739

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RytaryCarbidopa/Levodopa63$105,472
GocovriAmantadine Hcl21$90,253
Carbidopa-Levodopa ErCarbidopa/Levodopa186$16,055
Carbidopa-LevodopaCarbidopa/Levodopa239$12,826
AmantadineAmantadine Hcl62$6,099
Midodrine Hcl74$4,056
Pramipexole DihydrochloridePramipexole Di-Hcl26$2,595
Quetiapine Fumarate46$1,435
Baclofen20$1,110
Duloxetine Hcl37$922
Gabapentin44$901
Fludrocortisone Acetate33$828
Donepezil Hcl54$729
Primidone23$651
Bupropion XlBupropion Hcl29$606

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MDD US Operations, LLCGocovri$2,287$90,25321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Winter Park

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →